EMEA-001460-PIP01-13-M05
Key facts
Invented name |
Genvoya
|
Active substance |
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0435/2020
|
PIP number |
EMEA-001460-PIP01-13-M05
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Gilead Sciences International Ltd
Tel. +44 (0)1223 897300 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001460-PIP01-13-M05
|
Compliance opinion date |
25/06/2021
|
Compliance outcome |
positive
|